Bio-Rad launches run controls for multiplexed respiratory PCR assays

Dec. 2, 2020

Bio-Rad Laboratories has announced the launch of its SARS-CoV-2, Flu, RSV Positive and Negative Run Controls. The products enable laboratories to evaluate day-to-day and lot-to-lot variation of their multiplexed molecular assay and to test for operator proficiency, according to a press release from Bio-Rad.

The SARS-CoV-2, Flu, RSV Positive Run Control is manufactured with whole organism SARS-CoV-2, Influenza A, Influenza B and RSV (A). The product is formulated in a synthetic matrix and contains human genomic DNA.

The SARS-CoV-2, Flu, RSV Negative Run Control is negative for SARS-CoV-2, Influenza A, Influenza B and RSV (A) and is formulated in a synthetic matrix and contains human genomic DNA.

Visit Bio-Rad for more news